Volume | 7,064 |
|
|||||
News | - | ||||||
Day High | 2.50 | Low High |
|||||
Day Low | 2.4058 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Incannex Healthcare Ltd | IXHL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.50 | 2.4058 | 2.50 | 2.54 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
147 | 7,064 | $ 2.47 | $ 17,452 | - | 0.80 - 12.68 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:28:47 | 100 | $ 2.49 | USD |
Incannex Healthcare Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
793.66k | 15.87M | - | 1.01M | -19.98M | -1.26 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Incannex Healthcare News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IXHL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.34 | 2.60 | 2.2901 | 2.47 | 27,838 | 0.15 | 6.41% |
1 Month | 2.89 | 2.97 | 2.13 | 2.48 | 20,777 | -0.40 | -13.84% |
3 Months | 4.70 | 8.4697 | 2.13 | 5.71 | 336,715 | -2.21 | -47.02% |
6 Months | 1.10 | 12.68 | 0.80 | 5.83 | 198,741 | 1.39 | 126.36% |
1 Year | 2.15 | 12.68 | 0.80 | 4.87 | 132,002 | 0.34 | 15.81% |
3 Years | 11.00 | 90.00 | 0.80 | 7.22 | 89,396 | -8.51 | -77.36% |
5 Years | 11.00 | 90.00 | 0.80 | 7.22 | 89,396 | -8.51 | -77.36% |
Incannex Healthcare Description
Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. |